Avectas is a cell engineering business focused on improving the cost, manufacturing, and patient outcomes for the next generation of cellular therapies. Avectas is developing a unique delivery technology platform, Solupore®, to enable the ex-vivo manufacture of gene-modified cell therapy products, with partners.

Biotechnology

Avectas

Michael Maguire

Dr Ann Brady

Shane Finnegan

Sinead Dempsey

Gillian Hendy

Eoin Heffernan

Kieran Reilly

kartik srinivasan

Lisa O'Flynn

Scientific Research and Development

Leadership Team

Scientific Advisors and Technical Experts

Engineering and Technical Roles

Project Management and Development

Business Development and Partnerships

Teams at Avectas